Zealand Pharma: ”We’re not looking for a needle in a haystack”
According to executive David Solomon Zealand Pharma has the development of a very specific drug in mind in connection with the company’s collaboration deal with an American partner.
He can’t discuss the specific details, but David Solomon does reveal that the newly agreed deal with American Protagonist Therapeutics has been signed with the development of a very specific drug in mind.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
